03.12.25 -- Talent Logistics Turns Biotech Winter To Hiring Spring

Explore how shifting demand for oligos and peptides is driving outsourcing relationships and innovation in CDMO partnerships. Join our next Outsourced Pharma Live as we cover best practices for outsourcing these specialized therapeutics, focusing on capacity, regulatory challenges, and technology transfer. Register today to learn about the unique challenges and opportunities in scaling production for these complex molecules.

Explore the complexities of formulation maps for amorphous solid dispersions (ASDs) and the critical salt screening criteria essential for selecting formulations during early-phase screening.

From the digital infrastructure needed to enable a collaborative approach, to the quality systems and analytical methods, effective tech transfer relies on the careful consideration of a variety of factors.

Learn why pharmaceutical companies must invest in specialized expertise to develop scalable, safe, and efficient manufacturing processes for highly potent oral solid dose products.

Review the latest trends and solutions in inhaled drug delivery, with a focus on overcoming dry powder formulation challenges to advance next-generation therapeutics.

A recent project applied process improvement methodology to the process validation step that ultimately provided not only an optimized, robust process but also an economic advantage.

See how the preventative approach an emerging biotech company took to mitigate risks and identify potential concerns before their FDA inspection and NDA submission ultimately led to success.

Join Outsourced Pharma Live for an in-depth examination of how the BIOSECURE Act impacted risk management, compliance, and the future of global outsourcing in drug development and manufacturing.

Consider using Kneat: Project-Ready, a platform that allows your company to utilize a validated Kneat instance to execute your projects without start-up and ongoing maintenance.

Our integrated GMP manufacturing services for oral dosage forms offer a full complement of analytical development and testing capabilities.

We’ve helped develop and commercialize multiple particle engineering based drug delivery platforms and supported development and commercialization of many enhanced drug products.

Our tablet presses and encapsulating tools, combined with Natoli's expertise in blending, granulation, and tableting, ensure that formulations are transformed into market-ready pharmaceuticals.